![George Kegler](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
George Kegler
Director/Board Member at
ENVERIC BIOSCIENCES, INC.
Net worth: 10 823 $ as of 2026-08-30
Profile
George A. Kegler is currently an Independent Director at Enveric Biosciences, Inc. since 2020.
Former positions include Director at Jay Pharma, Inc. (Canada) from 2020 to 2025, President-Specialty Generics Business at Keenova Therapeutics Plc, Chief Financial Officer at Convatec, Inc., and Vice President-Finance at Keenova Therapeutics Plc from 2016 to 2018.
Education includes undergraduate studies at the University of Missouri and an MBA from St. Louis University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-05-31 | 7,900 ( 0.18% ) | 10 823 $ | 2026-08-30 |
George Kegler active positions
| Companies | Position | Start |
|---|---|---|
| ENVERIC BIOSCIENCES, INC. | Director/Board Member | 2020-12-29 |
Former positions of George Kegler
| Companies | Position | End |
|---|---|---|
Jay Pharma, Inc. (Canada)
 Jay Pharma, Inc. (Canada) Pharmaceuticals: OtherHealth Technology Develops cannabinoid medicines and combination therapies | Director/Board Member | 2025-03-14 |
ConvaTec, Inc.
 ConvaTec, Inc. Medical SpecialtiesHealth Technology Develops and manufactures products for the ostomy management, advanced chronic and acute wound care and continence care services | Director of Finance/CFO | 2012-04-25 |
| MALLINCKRODT PLC | Director of Finance/CFO | - |
| MALLINCKRODT PLC | Corporate Officer/Principal | - |
Training of George Kegler
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
20
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Keenova Therapeutics Plc
 Keenova Therapeutics Plc BiotechnologyHealth Technology Develops therapeutics for rheumatology, ophthalmology, nephrology, neurology, pulmonology, orthopedics, urology and neonatal respiratory problems | Health Technology |
University of Missouri
 University of Missouri Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ConvaTec, Inc.
ConvaTec, Inc. Medical SpecialtiesHealth Technology Develops and manufactures products for the ostomy management, advanced chronic and acute wound care and continence care services | Health Technology |
St. Louis University
 St. Louis University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Jay Pharma, Inc. (Canada)
Jay Pharma, Inc. (Canada) Pharmaceuticals: OtherHealth Technology Develops cannabinoid medicines and combination therapies | Health Technology |
Enveric Biosciences, Inc.
 Enveric Biosciences, Inc. Pharmaceuticals: OtherHealth Technology Develops cannabinoid medicines and combination therapies | Health Technology |
- Stock Market
- Insiders
- George Kegler
